Brief: Iteos Promotes Yvonne Mcgrath To Chief Scientific Officer
10/01/2022 12:51
Jan 10 (Reuters) - Iteos Therapeutics Inc ITOS.O :
* ITEOS PROVIDES CLINICAL DEVELOPMENT PLANS AND PROMOTES
YVONNE
MCGRATH, PH.D. TO CHIEF SCIENTIFIC OFFICER
* ITEOS THERAPEUTICS INC - PLANS TO INITIATE VARIOUS
COMBINATIONS
OF POTENTIAL NEXT GENERATION IMMUNO-ONCOLOGY AGENTS
* ITEOS THERAPEUTICS INC - ENTERING A PERIOD OF EXECUTION
FROM A
CLINICAL DEVELOPMENT PERSPECTIVE, WITH 11 CLINICAL STUDIES
ONGOING OR EXPECTED TO START
Source text for Eikon: ID:nGNX4rylpx
Further company coverage: ITOS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on iTeos Therapeutics
See all newsIteos Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Iteos Therapeutics Inc expected to post a loss of $1.01 a share - Earnings Preview
Brief: Iteos Therapeutics Enters Into Agreement To Be Acquired By Concentra Biosciences For $10.047 In Cash Per Share Plus A Contingent Value Right
U.S. STOCKS ON THE MOVE-Nvidia, Salesforce, Kestrel Group
U.S. STOCKS ON THE MOVE-Dick's Sporting Goods, Sonic Automotive